Tiberend Strategic Advisors

What Tiberend Strategic Advisors does

Tiberend Strategic Advisors (TSAI) is a privately held, full-service investor and corporate communications advisory firm specializing in the healthcare and life sciences industry. Founded in 1989 and headquartered in New York, the firm operates as a boutique consultancy serving healthcare and life sciences clients with investor relations and corporate communications services; its own descriptive positioning frames it as a specialist serving the communications needs of life sciences companies and their investors.

The firm is small by headcount (1-10 employees) and founder-led, with Gregory Tiberend serving as President and CEO, Jason Rando as EVP and COO, and Dave Schemelia as Senior Vice President. This senior-heavy structure is typical of a boutique advisory practice where revenue is driven by direct senior practitioner time rather than by junior staffing or productized offerings. The firm is privately held with no disclosed funding rounds, parent company, subsidiaries, or public ticker; ownership, investor base, and financial performance (revenue, profitability, headcount trajectory) are not disclosed in the available source material, and the company's own website rendered only a verification/loading page at the time of data collection, providing no further detail on services, pricing, clients, or technology stack.

Business model mechanics (pricing model, contract structure, average engagement size, customer segmentation, geographic footprint beyond New York, and use of any proprietary tools or platforms) are not documented in the input data, so they cannot be characterized beyond the general framing of a fee-for-service investor and corporate communications practice in healthcare and life sciences. The absence of disclosed customers, partnerships, awards, certifications, or product launches in the source data materially limits further characterization.

Name

Tiberend Strategic Advisors

Website

https://tiberend.com

Company type

Private

Founded year

1989

Headcount range

1–10 employees

Short description

Tiberend Strategic Advisors is a privately held, New York-based boutique advisory firm providing investor and corporate communications services to healthcare and life sciences clients. Founded in 1989, it operates with a small senior-led team.

Ownership category

akta.pro rank

Product category

Healthcare Communications Services

NAICS

Advertising, Public Relations, and Related Services (5418)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Healthcare & Life Sciences PR (BPAFADAJ)

akta.pro secondary industry

Corporate & Financial Communications PR (MPAAADAA)

Keywords

• Healthcare communications
• Investor relations
• Corporate communications
• Life sciences PR
• Strategic advisory

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations

Core offering

Full-service investor and corporate communications firm specializing in the healthcare and life sciences industry. The firm provides strategic communications counsel to healthcare and life sciences organizations, including investor relations and corporate communications services.

Differentiator

Problem solved

Functional benefit

Products and services

• Investor Relations
• Corporate Communications
• Strategic Communications Advisory

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• LifeSci Communications: LifeSci Communications is a healthcare- and life-sciences-focused public relations and communications agency. It is a direct peer of TSAI in scope (healthcare PR/comms specialty) and client type (biotech, pharma, medtech).
• Canale Communications: Canale Communications is a life sciences-focused public relations and investor relations firm. Its exclusive healthcare/life sciences communications orientation makes it a direct comparable to TSAI's niche.
• Russo Partners: Russo Partners is a healthcare-focused public relations and investor relations advisory. Its exclusive healthcare/life sciences orientation and IR-comms blend make it a close comparable to TSAI.
• Rx Communications Group: Rx Communications Group provides strategic communications and investor relations services to life sciences companies. It is a direct boutique peer to TSAI in the healthcare IR/PR space.
• Burns McClellan: Burns McClellan is a healthcare-dedicated public relations and investor relations firm. It serves biotech, pharma, and medtech clients with similar communications and IR services as TSAI.
• PondelWilkinson Inc. PondelWilkinson is an investor relations and corporate communications firm with a strong healthcare/life sciences practice. Its IR-first, sector-focused model is closely comparable to TSAI's positioning.
• LaVoieHealthScience: LaVoieHealthScience is an integrated investor relations and public relations agency focused on health and life sciences. It directly overlaps with TSAI's combined investor + corporate communications offering for healthcare clients.
• Argot Partners: Argot Partners is a strategic communications and investor relations firm specializing in life sciences and healthcare. It competes for the same biotech and pharma mandates that TSAI serves.

Broad incumbents

• Westwicke Partners (ICR Westwicke): Westwicke Partners, now part of ICR, is a healthcare-specialist IR and strategic advisory firm with a larger scale and broader service menu. It is comparable as an established healthcare IR incumbent rather than as a direct same-size competitor.
• Real Chemistry: Real Chemistry (formerly W2O Group) is a large healthcare-focused marketing, communications, and data firm. It is comparable as a broader incumbent offering overlapping healthcare communications capabilities at significantly greater scale than TSAI.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/tiberend
• Facebookfacebook.com/TiberendStrategicAdvisors
• LinkedInlinkedin.com/company/tiberend-strategic-advisors-inc.

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tiberend Strategic Advisors